FUNCTIONAL AND STRUCTURAL CHANGES OF THE CENTRAL NERVOUS SYSTEM DEPENDING ON BODY MASS INDEX IN TYPE 2 DIABETES MELLITUS
DOI:
https://doi.org/10.5281/zenodo.20094553Keywords:
type 2 diabetes mellitus, body mass index, central nervous system, obesity, cognitive impairment, neurodegeneration, brain structure, metabolic disordersAbstract
Type 2 diabetes mellitus is one of the most common metabolic diseases associated with chronic hyperglycemia and multiple systemic complications. Obesity and increased body mass index are considered important risk factors contributing to the progression of neurological complications in diabetic patients. The aim of this article is to study functional and structural changes of the central nervous system depending on body mass index in patients with type 2 diabetes mellitus. The analysis demonstrates that increased body mass index aggravates metabolic disturbances, vascular dysfunction, neuroinflammation, and neuronal damage, leading to cognitive impairment and structural brain alterations. Early diagnosis and комплексный management of obesity in diabetic patients may reduce the progression of central nervous system dysfunction.
Downloads
References
1.American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2024.
2.American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2024.
3.Arnold S. E., Arvanitakis Z., Macauley-Rambach S. L., et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease. Nature Reviews Neurology. 2018;14(3):168–181.
4.Moran C., Beare R., Phan T. G., et al. Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology. 2015;85(13):1123–1130.
5.Mansur R. B., Brietzke E., McIntyre R. S. Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and depression. Neuroscience & Biobehavioral Reviews. 2015;52:89–104.
6.Yau P. L., Javier D., Ryan C. M., Tsui W. H., Ardekani B. A., Ten S., Convit A. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia. 2010;53(11):2298–2306.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India